Case File
efta-02558460DOJ Data Set 11OtherEFTA02558460
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02558460
Pages
6
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Barrett, Paul S
Sent:
Thursday, July 26, 2012 7:01 PM
To:
Jeffrey
Cc:
Giuffrida, David
Subject:
RE: Revised Portfolio
We own 1.2MM of the Sprint 6% 2016 bonds that have rallied back to 99 from the lows of 79 in November. I think we
should sell and look for other replacement candidates. We are up 51K on the position.
Let me know
Paul
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
JPMorgan Private Bank
320 Park Avenue, 14th Floor, New York, NY 10022
NMLS IDe 853441
From: Jeffrey [mailto:[email protected]]
Sent: Thursday, July 26, 2012 12:35 PM
To: Barrett, Paul S
Subject: Re: Revised Portfolio
EFTA_R1_01718167
EFTA02558460
Not till sept
Sorry for all the typos .Sent from my iPhone
On Jul 26, 2012, at 12:10 PM, "Barrett, Paul S" d
>
wrote:
Hi Jeffrey
I left a message with Leslie.
Do you need any additional follow up regarding the portfolio?
Paul
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
JPMorgan Private Bank
320 Park Avenue, 14th Floor, New York, NY 10022
NMLS II:41853441
From: Barrett, Paul S
Sent: Tuesday, July 17, 2012 3:55 PM
To: 'Jeffrey Epstein'
Cc: Giuffrida, David
Subject: Revised Portfolio
2
EFTA_R1_01718168
EFTA02558461
Hi Jeffrey
Here is a revised portfolio sample that does not employ leverage. We added some gold exposure and increased
the oil weighting. Remember that the coupons on a structured note will knock out if we hit the buffer level (continuous)
or finish below the buffer (at expiry).
Proposed Portfolio
Leveraged Weight
High Yield
3
EFTA_R1_01718169
EFTA02558462
20.00%
Yield
JPM High Yield Bond Fund
20.00%
6.36%
Bank Preferreds/Lower Tier II Bonds
15.00%
Yield
RBS 7.25% Pfds
8.50%
Ally B Pfds
4.00%
4
EFTA_R1_01718170
EFTA02558463
4.00%
7.95%
Rabobank 8.40% Pfds
7.85%
Bank of America 8.125% Pfd
2.00%
6.60%
GE 7.125% Pfd
5.90%
Emerging Markets
10.00%
Yield
3.00%
2.00%
PDVSA 5% 2015 (USD Denominated)
5
EFTA_R1_01718171
EFTA02558464
5.00%
11.75%
BRL Linked Market Plus Note (8% coupon / 25% At expiry Buffer)
5.00%
8.00%
Equity Linked Notes
22.50%
Coupon
This email is confidential and subject to important disclaimers and conditions including on offers for the purchase or sale
of securities, accuracy and completeness of information, viruses, confidentiality, legal privilege, and legal entity
disclaimers, available at http://www.jpmorgan.com/pages/disclosures/email.
6
EFTA_R1_01718172
EFTA02558465
Technical Artifacts (8)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Phone
2558460Phone
2558461Phone
2558462Phone
2558463Phone
2558464Phone
2558465URL
http://www.jpmorgan.com/pages/disclosures/emailRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.